<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001673277</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000818686</issuerCik>
      <issuerName>TEVA PHARMACEUTICAL INDUSTRIES LTD</issuerName>
      <secFileNumber>001-16174</secFileNumber>
      <issuerAddress>
        <com:street1>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</com:street1>
        <com:street2>124 DVORA HANEVI'A ST.</com:street2>
        <com:city>TEL AVIV</com:city>
        <com:stateOrCountry>L3</com:stateOrCountry>
        <com:zipCode>6944020</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972 (3) 914-8213</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Francis Richard D</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>PRESIDENT AND CEO</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>CITIGROUP GLOBAL MARKETS INC</name>
        <address>
          <com:street1>390 GREENWICH STREET</com:street1>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10013</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>6153</noOfUnitsSold>
      <aggregateMarketValue>211355.55</aggregateMarketValue>
      <noOfUnitsOutstanding>1164426972</noOfUnitsOutstanding>
      <approxSaleDate>06/05/2026</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <acquiredDate>06/05/2025</acquiredDate>
      <natureOfAcquisitionTransaction>RESTRICTED SHARE UNIT AWARD VESTING</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>13043</amountOfSecuritiesAcquired>
      <paymentDate>06/05/2026</paymentDate>
      <natureOfPayment>COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>RICHARD FRANCIS</name>
        <address>
          <com:street1>124 DVORA HANEVI'A ST.</com:street1>
          <com:city>TEL AVIV</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6944020</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <saleDate>03/05/2026</saleDate>
      <amountOfSecuritiesSold>20025</amountOfSecuritiesSold>
      <grossProceeds>634159.71</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>SECTION 3E SHARES OR OTHER UNITS OUTSTANDING BASED ON ORDINARY SHARES. SHARES WERE SOLD PURSUANT TO A 10B51 PLAN ESTABLISHED IN NOV 2025 TO COVER THE VESTING AND SETTLEMENT OF EQUITY AWARDS VIA SELL TO COVER OBLIGATIONS</remarks>
    <noticeSignature>
      <noticeDate>06/05/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>11/14/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>CONFORMED SIGNATURE ON FILE</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
